Media visibility and costs of new medicines under examination—what does the media highlight?
A study conducted by the University of Eastern Finland and Fimea found that the Finnish news media has given GLP-1 agonists used to treat obesity, such as semaglutide, a great deal of attention while many other new medicines ...
Sep 10, 2025
0
0


